Biodexa Pharmaceuticals (BDRX) Revenue & Revenue Breakdown
Biodexa Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$381.00K
Latest Revenue (Q)
$41.50K
Biodexa Pharmaceuticals Revenue by Period
Biodexa Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $381.00K | -45.49% |
| 2022-12-31 | $699.00K | 20.93% |
| 2021-12-31 | $578.00K | 68.51% |
| 2020-12-31 | $343.00K | -49.11% |
| 2019-12-31 | $674.00K | -65.22% |
| 2018-12-31 | $1.94M | 95.96% |
| 2017-12-31 | $989.00K | -25.25% |
| 2016-12-31 | $1.32M | -3.78% |
| 2015-12-31 | $1.38M | 775.80% |
| 2014-12-31 | $157.00K | 6.80% |
| 2013-12-31 | $147.00K | 100.00% |
| 2012-12-31 | - | - |
Biodexa Pharmaceuticals generated $381.00K in revenue during NA 2023, up -45.49% compared to the previous quarter, and up 19.66% compared to the same period a year ago.
Biodexa Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $41.50K | - |
| 2023-09-30 | $41.50K | -72.15% |
| 2023-06-30 | $149.00K | - |
| 2023-03-31 | $149.00K | 29.00% |
| 2022-12-31 | $115.50K | - |
| 2022-09-30 | $115.50K | -50.64% |
| 2022-06-30 | $234.00K | - |
| 2022-03-31 | $234.00K | 164.41% |
| 2021-12-31 | $88.50K | - |
| 2021-09-30 | $88.50K | -55.86% |
| 2021-06-30 | $200.50K | - |
| 2021-03-31 | $200.50K | 129.14% |
| 2020-12-31 | $87.50K | - |
| 2020-09-30 | $87.50K | 4.17% |
| 2020-06-30 | $84.00K | - |
| 2020-03-31 | $84.00K | -62.83% |
| 2019-06-30 | $226.00K | - |
| 2019-03-31 | $226.00K | -17.67% |
| 2018-06-30 | $274.50K | - |
| 2018-03-31 | $274.50K | 6.40% |
| 2017-12-31 | $258.00K | - |
| 2017-09-30 | $258.00K | 9.09% |
| 2017-06-30 | $236.50K | - |
| 2017-03-31 | $236.50K | -106.54% |
| 2016-12-31 | $-3.61M | -281.97% |
| 2016-09-30 | $1.99M | 34.60% |
| 2016-06-30 | $1.48M | - |
| 2016-03-31 | $1.48M | 180.78% |
| 2015-12-31 | $525.50K | - |
| 2015-09-30 | $525.50K | 224.38% |
| 2015-06-30 | $162.00K | - |
| 2015-03-31 | $162.00K | 167.77% |
| 2014-12-31 | $60.50K | - |
| 2014-09-30 | $60.50K | 236.11% |
| 2014-06-30 | $18.00K | - |
| 2014-03-31 | $18.00K | -72.52% |
| 2013-12-31 | $65.50K | - |
| 2013-09-30 | $65.50K | 718.75% |
| 2013-06-30 | $8.00K | - |
| 2013-03-31 | $8.00K | - |
Biodexa Pharmaceuticals generated $41.50K in revenue during Q4 2023, up 0.00% compared to the previous quarter, and up 35.93% compared to the same period a year ago.